Discovering the 21st Amino Acid ... Again?

Pyrrolysine, the 22nd amino acid, discovered in 2002, might lay claim to being the 21st following the discovery by Ohio State University researchers that, like the twenty canonical amino acids, it is translated by the genetic code using a natural tRNA synthetase-tRNA pair.1 Pyrrolysine is the first new amino acid discovered since selenocysteine in 1986, but the latter results from modification of serine after attachment to its tRNA.Microbiologist Joseph Krzycki and chemist Michael Chan discovere

Written byStuart Blackman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Pyrrolysine, the 22nd amino acid, discovered in 2002, might lay claim to being the 21st following the discovery by Ohio State University researchers that, like the twenty canonical amino acids, it is translated by the genetic code using a natural tRNA synthetase-tRNA pair.1 Pyrrolysine is the first new amino acid discovered since selenocysteine in 1986, but the latter results from modification of serine after attachment to its tRNA.

Microbiologist Joseph Krzycki and chemist Michael Chan discovered pyrrolysine, encoded by stop codon UAG, in certain methyltransferases of the methanogenic anaerobe Methanosarcina barkeri. Krzycki says there were suspicions that pyrrolysine results from a postactivation modification of lysine, but his latest collaboration with Chan reveals that a specific tRNA is charged directly with pyrrolysine.

By expressing the pyrrolysine-specific synthetase and tRNA and the M. barkeri methyltransferase in Escherichia coli, Krzycki and Chan showed that pyrrolysine added to the culture became incorporated into the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies